Suppr超能文献

[生长激素部分特发性缺乏所致身材矮小。TW2方法在评估重组人生长激素治疗中的作用]

[Short stature due to a partial idiopathic deficiency of the growth hormone. The role of the TW2 method in assessing treatment with r-hGH].

作者信息

Gibilisco G, De Liperi A, Giusti P, Tozzini A, Carafoli D, Celandroni A, Rolla M, Calderazzi A

机构信息

Istituto di Radiologia, Università di Pisa.

出版信息

Radiol Med. 1996 Mar;91(3):181-6.

PMID:8628927
Abstract

The Tanner-Whitehouse 2 (TW2) method to assess skeletal maturation (reviewed by Nicoletti for the Italian population) was used to study, from January, 1991, to December, 1994, a series of 26 Italian patients. The patients, 18 men (69.3%) and 8 women (30.7%), came from inhomogeneous family stocks and were all affected with short stature due to partial idiopathic GH deficiency; they were treated with replacement therapy with the biosynthetic recombinant human growth hormone (r-hGH). Each patient underwent 3 wrist and left hand radiographs, the first one made on the basis of medical and endocrinologic assessment. The patients were reexamined after one and two years of treatment with the analysis of stature growth and of the skeletal maturation of hand bones. At one year, the average chronological age of our patients was 12.42 year (range: 9.4-15.2 years), their average bone age was 11.13 years (range: 6.5-14 years) and their average height was 137.81 cm (range: 117-155.5 cm). The patients were then retrospectively examined on the basis of bone maturation and final height, at the end of two years' therapy. At the end of treatment, height was above the third percentile in all patients and therefore within the expected personal target on the basis of genetic stature. The TW2 indexes of bone maturation, after one year of treatment, had increased by 44.84% (range: 27-77%) of the total maturation increase at two years. Moreover, after one year of treatment, average stature increase was 55.81% (range: 42-72%) of the total stature increase at two years. After two years of treatment, TW2 indexes showed an average 55.16% increase in bone maturation (range: 23-73%) of total maturation and average stature increase was 44.19% (range: 28-56%) of the total stature increase. Our results confirmed that skeletal growth and bone maturation are two distinct processes. Particularly, we noted that, while after one year of r-hGH therapy skeletal growth (especially in the long bones) prevails over bone maturation, after two years maturation prevails. In conclusion, our experience confirms the TW2 method as a simple and highly informative method which can be used in any radiologic center.

摘要

采用坦纳-怀特豪斯2型(TW2)方法评估骨骼成熟度(由尼科letti针对意大利人群进行综述),对1991年1月至1994年12月期间的26例意大利患者进行了研究。这些患者中,18名男性(69.3%)和8名女性(30.7%),来自不同的家族背景,均因部分特发性生长激素缺乏而身材矮小;他们接受了生物合成重组人生长激素(r-hGH)替代治疗。每位患者均接受了3次手腕和左手X线片检查,第一次检查是基于医学和内分泌评估进行的。在治疗1年和2年后,对患者进行复查,分析身高增长和手部骨骼的骨骼成熟度。治疗1年后,我们患者的平均实足年龄为12.42岁(范围:9.4 - 15.2岁),平均骨龄为11.13岁(范围:6.5 - 14岁),平均身高为137.81厘米(范围:117 - 155.5厘米)。然后在两年治疗结束时,根据骨骼成熟度和最终身高对患者进行回顾性检查。治疗结束时,所有患者的身高均高于第3百分位数,因此在基于遗传身高的预期个人目标范围内。治疗1年后,TW2骨骼成熟度指数增加了两年总成熟度增加量的44.84%(范围:27 - 77%)。此外,治疗1年后,平均身高增加量为两年总身高增加量的55.81%(范围:42 - 72%)。治疗两年后,TW2指数显示骨骼成熟度平均增加了总成熟度的55.16%(范围:23 - 73%),平均身高增加量为总身高增加量的44.19%(范围:28 - 56%)。我们的结果证实,骨骼生长和骨骼成熟是两个不同的过程。特别是,我们注意到,在r-hGH治疗1年后,骨骼生长(尤其是长骨)超过骨骼成熟,而在两年后成熟占主导。总之,我们的经验证实了TW2方法是一种简单且信息丰富的方法,可在任何放射学中心使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验